ARTICLES - Resistance-Modifying Agents. 5. Synthesis and Biological Properties of Quinazolinone Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose) Polymerase (PARP)
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1998 |
---|---|
Erschienen: |
1998 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Journal of medicinal chemistry - 41(1998), 26, Seite 5247-5256 |
Beteiligte Personen: |
Griffin, Roger J. [VerfasserIn] |
---|
BKL: |
---|
Umfang: |
10 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1546612475 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1546612475 | ||
003 | DE-627 | ||
005 | 20230511083109.0 | ||
007 | tu | ||
008 | 990203s1998 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a SW990105 |
035 | |a (DE-627)OLC1546612475 | ||
035 | |a (DE-599)GBVOLC1546612475 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 540 |a 610 |
084 | |a PHARM |2 fid | ||
084 | |a 44.42 |2 bkl | ||
100 | 1 | |a Griffin, Roger J. |e verfasserin |4 aut | |
245 | 1 | 0 | |a ARTICLES - Resistance-Modifying Agents. 5. Synthesis and Biological Properties of Quinazolinone Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose) Polymerase (PARP) |
264 | 1 | |c 1998 | |
300 | |a 10 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Srinivasan, Sheila |4 oth | |
700 | 1 | |a Bowman, Karen |4 oth | |
700 | 1 | |a Calvert, A.Hilary |4 oth | |
700 | 1 | |a Curtin, Nicola J. |4 oth | |
700 | 1 | |a Newell, David R. |4 oth | |
700 | 1 | |a Pemberton, Louise C. |4 oth | |
700 | 1 | |a Golding, Bernard T. |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Journal of medicinal chemistry |d Easton, Pa. : American Chemical Society, 1963 |g 41(1998), 26, Seite 5247-5256 |w (DE-627)129545201 |w (DE-600)218133-2 |w (DE-576)014995336 |x 0022-2623 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:1998 |g number:26 |g pages:5247-5256 |g extent:10 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_48 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_130 | ||
912 | |a GBV_ILN_168 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2221 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4028 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4082 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4309 | ||
912 | |a GBV_ILN_4314 | ||
936 | b | k | |a 44.42 |q AVZ |
951 | |a AR | ||
952 | |d 41 |j 1998 |e 26 |h 5247-5256 |g 10 |